Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
Idifarma Desarrollo Farmacéutico
Idifarma Desarrollo Farmacéutico
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
IPS opens new branches in the UK and US
US-based IPS (Integrated Project Service) has expanded its reach by opening new branches in Alderley Park and Texas
Pfizer wins 2024 ISPE FOYA award with "central pool concept" API facility design
Pfizer has won the Operations, Project Execution category at 2024's ISPE Facility of the Year Awards. Purtias Asgard completed work as the cleanroom subcontractor for this...
Medhini Group announces partnership with sustainable engineering consultancy
Medhini Group and TERAO Asia have joined forces to advance sustainable and green industrial projects in Malaysia
Cleanroom Technology Conference UK 2024: Agenda launch
Hear from NASA, AstraZeneca and STERIS at the Cleanroom Technology Conference 2024. This year's agenda has launched and delegates will have the opportunity to converse with...
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Idifarma appoints new head of site
Spanish CDMO has appointed Alfredo Gómez as its head of site
Manufacturing
Idifarma announces new Director of Operations
Daniel Rivero will join the Spanish CDMO from 3P Biopharmaceuticals
Pharmaceutical
Idifarma begins GMP operation of spray drying for HAPIs
The installed spray drying capacity is for handling highly potent drugs of up to Category 4 OEL/OEB
Manufacturing
Idifarma gets spray drying machine for highly potent drugs
New GMP spray drying capabilities make the Spanish CDMO one of the few in the world to offer the technology for highly potent drugs up to Category 4 OEL/OEB
Subscribe now